Lipocine's total assets for Q2 2025 were $18.58M, a decrease of -9.38% from the previous quarter. LPCN total liabilities were $1.45M for the fiscal quarter, a 11.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.